Delivery Order SPE2DB22D3016-SPE2DB25FBDR9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $1,385.52. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. ORGOVYX...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a single pharmaceutical procurement from the vendor's corporate office located in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in the treatment of...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.52 for ORGOVYX 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. ORGOVYX is a prescription medication used in the treatment of prostate cancer, reflecting DLA's ongoing...
- The Defense Logistics Agency has awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30. The contract, designated as non-competitive with a firm fixed price structure, is scheduled for completion by August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order operates as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of ORGOVYX 120 MG tablets (30-count units) with a ceiling value of $1,385.52. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count unit dose) valued at $1,385.52 with a firm fixed price arrangement. This non-competitive, non-set-aside delivery order was awarded on August 8, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of ORGOVYX 120 mg tablets in packages of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,385.52, with an ultimate completion date of August 19, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count unit of use packaging) valued at $1,385.52, with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive award, issued on July 24, 2025, with an ultimate completion date of August 14, 2025, utilizes firm fixed price pricing with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 MG tablets, quantity 30s, with a ceiling value of $4,156.56. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. ORGOVYX is a prescription medication used in the...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDR9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the prime contractor and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in the treatment of prostate cancer, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, positioning AmerisourceBergen as a key pharmaceutical distributor for the Department of Defense's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/31/25 |